The von Hippel-Lindau tumor suppressor gene inhibits hepatocyte growth factor/scatter factor-induced invasion and branching morphogenesis in renal carcinoma cells

Molecular and Cellular Biology

Volumn 19, Issue 9, 1999, Pages 5902-5912

  Koochekpour, Shahriar ^a   Jeffers, Michael ^a   Wang, Paul H ^b   Gong, Changning ^b   Taylor, Gregory A ^a   Roessler, Lisa M ^a   Stearman, Robert ^c   Vasselli, James R ^c   Stetler Stevenson, William G ^c   Kaelin Jr , William G ^d   Linehan, W Marston ^c   Klausner, Richard D ^c   Gnarra, James R ^b   Vande Woude, George F ^a,c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT PROTEIN; SCATTER FACTOR;

ARTICLE; CANCER INVASION; CELL CYCLE; CELL LINE; CONTROLLED STUDY; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; MORPHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE; VON HIPPEL LINDAU DISEASE;

EID: 0032795938     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.19.9.5902     Document Type: Article

References (59)

1. Aznavoorian, S., A. N, Murphy, W. G. Stetler-Stevenson, and L. A. Liotta. 1993. Molecular aspects of tumor cell invasion and metastasis. Cancer 71: 1368-1383.
2. Curran, T., G. Peters, C. Van Beveren, N. M. Teich, and I. M. Verma. 1982. FBJ murine osteosarcoma virus: identification and molecular cloning of biologically active proviral DNA. J. Virol. 44:674-682.
3. Droz, D., N. Patey, F. Paraf, Y. Chretien, and J. Gogusev. 1994. Composition of extracellular matrix and distribution of cell adhesion molecules in renal cell tumors. Lab. Investig. 71:710-718.
4. Friedhelm, B., S. Riethmacher, S. Isenmann, A. Aaguzzi, and C. Birchmeier. 1995. Essential role for the c-met receptor in the migration of myogenic precursor cells into limb bud. Nature 376:768-771.
5. Gnarra, J. R., D. Duan, Y. Weng, J. S. Humphrey, D. Y. Chen, S. Lee, A. Pause, C. F. Dudley, F. Latif, I. Kuzmin, L. Schmidt, F. M. Duh, T. Stackhouse, F. Chen, T. Kishida, M. H. Wei, M. I. Lerman, B. Zbar, R. D. Klausner, and W. M. Linehan. 1996. Molecular cloning of the von Hippel-Lindau tumor suppressor gene and its role in renal carcinoma. Biochim. Biophys. Acta 1242:201-210.
6. Gnarra, J. R., K. Tory, Y. Weng, L. Schmidt, M. H. Wei, H. Li, F. Latif, S. Liu, F. Chen, F.-M. Duh, I. Lubensky, D. R. Duan, C. Florence, R. Pozzatti, M. M. Walther, N. H. Bander, H. B. Grossman, H. Brauch, S. Pomer, J. D. Brooks, W. B. Isaacs, M. I. Lerman, B. Zbar, and W. M. Linehan. 1994. Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat. Genet. 7:85-90.
7. Gnarra, J. R., S. Zhou, M. J. Merrill, J. R. Wagner, A. Krumm, E. Papavassiliou, E. H. Oldfield, R. D. Klausner, and W. M. Linehan. 1996. Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene. Proc. Natl. Acad. Sci. USA 93:10589-10594.
8. Heussen, C., and E. B. Dowdle. 1980. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal. Biochem. 102:196-202.
9. Igawa, T., S. Kanda, H. Kanetake, Y. Saitoh, A. Ichihara, Y. Tomita, and T. Nakamura. 1991. Hepatocyte growth factor is a potent mitogen for cultured rabbit renal tubular epithelial cells. Biochem. Biophys. Res. Commun. 174: 831-838.
10. Iliopoulos, O., A. Kibel, S. Gray, and W. G. J. Kaelin. 1995. Tumour suppression by the human von Hippel-Lindau gene product. Nat. Med. 1:822-826.
11. Iliopoulos, O., A. P. Levy, C. Jiang, W. G. Kaelin, Jr., and M. A. Goldberg. 1996. Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc. Natl. Acad. Sci. USA 93:10595-10599.
12. Iyer, A., T. E. Kmlecik, M. Park, I. Daar, D. Blair, K. J. Dunn, P. Sutrave, J. N. Ihle, M. Bodescot, and G. F. Vande Woude. 1990. Structure, tissue-specific expression, and transforming activity of the mouse met protooncogene. Cell Growth Differ. 1:87-95.
13. Jeffers, M., M. Fiscella, C. P. Webb, M. Anver, S. Koochekpour, and G. F. Vande Woude. 1998. The mutationally activated Met receptor mediates motility and metastasis. Proc. Natl. Acad. Sci. USA 95:14417-14422.
14. Jeffers, M., S. Rong, M. Oskarsson, M. Anver, and G. F. Vande Woude. 1996. Autocrine hepatocyte growth factor/scatter factor-Met signaling induces transformation and the invasive/metastatic phenotype in C127 cells. Oncogene 13:853-861.
15. Jeffers, M., S. Rong, and G. F. Vande Woude. 1996. Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-Met signalling in human cells concomitant with induction of the urokinase proteolysis network. Mol. Cell. Biol. 16:1115-1125.
16. Jefers, M., S. Rong, and G. F. Vande Woude. 1996. Hepatocyte growth factor/scatter factor-Met signalling in tumorigenicity and invasion/metastasis. J. Mol. Med. 74:505-513.
17. Kawaida, K., K. Matsumoto, H. Shimazu, and T. Nakamura. 1994. Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice. Proc. Natl. Acad. Sci. USA 91:4357-4361.
18. Khokha, R., P. Waterhouse, S. Yagel, P. K. Lala, C. M. Overall, G. Norton, and D. T. Denhardt. 1989. Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells. Science 243:947-950.
19. Knebelmann, B., S. Ananth, H. T. Cohen, and V. P. Sukhatme. 1998. Transforming growth factor alpha is a target for the von Hippel-Lindau tumor suppressor. Cancer Res. 58:226-231.
20. Konishi, T., T. Takehara, T. Tsujl, K. Ohsato, K. Matsumoto, and T. Nakamura. 1991. Scatter factor from human embryonic lung fibroblasts is probably identical to hepatocyte growth factor. Biochem. Biophys. Res. Commun. 180:765-773.
21. Koochekpour, S., M. Jeffers, S. Rulong, E. Kllneberg, G. Taylor, E. A. Hudson, J. H. Resau, and G. F. Vande Woude. 1997. Met and hepatocyte growth factor/scatter factor expression in human gliomas. Cancer Res. 57: 5391-5398.
22. Linehan, W. M., M. I. Lennan, and B. Zbar. 1995. Identification of the von Hippel-Lindau (VHL) gene. Its role in renal cancer. JAMA 273:564-570.
23. Liotta, L. A. 1986. Tumor invasion and metastases-role of the extracellular matrix: Rhoads Memorial Award lecture. Cancer Res, 46:1-7.
24. Lonergan, K. M., O. Iliopoulos, M. Ohh, T. Kamura, R. C. Conaway, J. W. Conaway, and W. G. Kaelin, Jr. 1998. Regulation of hypoxia-inducible roRNAs by the von Hippel-Lindau tumor suppressor protein requires binding to complexes containing elongins B/C and Cul2. Mol. Cell. Biol. 18:732-741.
25. Maher, E. R., and W. G. Kaelin, Jr. 1997. von Hippel-Lindau disease. Medicine (Baltimore) 76:381-391.
26. FAK) and promotes migration and invasion by oral squamous cell carcinoma cells. J. Biol. Chem. 269:31807-31813.
27. Matsumoto, K., and T. Nakamura. 1992. Hepatocyte growth factor: molecular structure, roles in liver regeneration, and other biological functions. Crit. Rev. Oncog. 3:27-54.
28. Matsumoto, K., and T. Nakamura. 1993. Roles of HGF as a pleiotropic factor in organ regeneration, p. 225-250. In I. D. Goldberg and E. M. Rosen (ed.), Hepatocyte growth factor-scatter factor and the Met Receptor, vol. 65. Birkhauser-Verlag, Basel, Switzerland.
29. Millan, J. C. 1989. Tumors of the kidney, p. 623-701. In G. S. Hill (ed.), Uropathology, vol. 2. Churchill Livingstone, New York, N.Y.
30. Montesano, R., K. Matsumoto, T. Nakamura, and L. Orci. 1991. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell 67:901-908.
31. Morikawa, K., S. M. Walker, M. Nakajima, S. Pathak, J. M. Jessup, and I. J. Fidler. 1988. Influence of organ environment on the growth, selection, and metastasis of human colon carcinoma cells in nude mice. Cancer Res. 48: 6863-6871.
32. Nagaike, M., S. Hirao, H. Tajima, S. Nojl, S. Taniguchi, K. Matsumoto, and T. Nakamura. 1991. Renotropic functions of hepatocyte growth factor in renal regeneration after unilateral nephrectomy. J. Biol. Chem. 266:22781-22784.
33. Nakajima, M., D. R. Welch, P. N. Belloni, and G. L. Nicolson. 1987. Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials. Cancer Res. 47:4869-4876.
34. Nakayama, Y., S. Naito, M. Ryuto, Y. Hata, M. Ono, K. Sueishi, S. Komiyama, H. Itoh, and M. Kuwano. 1996. An in vitro invasion model for human renal cell carcinoma cell lines mimicking their metastatic abilities. Clin. Exp. Metastasis 14:466-474.
35. Natali, P. G., M. Prat, M. R. Nicotra, A. Bigotti, M. Olivero, P. M. Comoglio, and M. F. Di Renzo. 1996. Overexpression of the met/HGF receptor in renal cell carcinomas. Int. J. Cancer 69:212-217.
36. Otani, N., T. Tsukamoto, N. Masumori, I. Saiki, J. Yoneda, and Y. Kumamoto. 1994. Influence of growth factors on in vitro invasiveness and type IV collagenolysis of human renal cell carcinoma cells. J. Urol. 151:223-226.
37. Otani, N., T. Tsukamoto, I. Saiki, J. Yoneda, T. Mitaka, and Y. Kumamoto. 1993. In vitro invasive potential and type IV collagenolytic activity of human renal cell carcinoma cells derived from primary and metastatic lesions. J. Urol. 149:1182-1185.
38. Pause, A., S. Lee, K. M. Lonergan, and R. D. Klausner. 1998. The von Hippel-Lindau tumor suppressor gene is required for cell cycle exit upon serum withdrawal. Proc. Natl. Acad. Sci. USA 95:993-998.
39. Prat, M., R. P. Narsimhan, T. Crepaldi, M. R. Nicotra, P. G. Natali, and P. M. Comoglio. 1991. The receptor encoded by the human c-MET oncogene is expressed in hepatocytes, epithelial cells and solid tumors. Int. J. Cancer 49:323-328.
40. Rong, S., M. Jeffers, J. H. Resau, I. Tsarfaty, M. Oskarsson, and G. F. Vande Woude. 1993. Met expression and sarcoma tumorigenicity. Cancer Res. 53: 5355-5360.
41. Rong, S., M. Oskarsson, D. Faletto, I. Tsarfaty, J. H. Ressu, T. Nakamura, E. Rosen, R. F. Hopkins, and G. F. Vande Woude. 1993. Tumorigenesis induced by co-expression of human hepatocyte growth factor and the human met protooncogene leads to high levels of expression of the ligand and receptor. Cell Growth Differ. 4:563-569.
42. Rang, S., S. Segal, M. Anver, J. H. Resau, and G. F. Vande Woude. 1994. Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation. Proc. Natl. Acad. Sci. USA 91:4731-4735.
43. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
44. Schultz, R. M., S. Silberman, B. Persky, A. S. Bajkowski, and D. F. Carmichael. 1988. Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells. Cancer Res. 48:5539-5545.
45. Siemeister, G., K. Weindel, K. Mohrs, B. Barleon, G. Martiny-Baron, and D. Manne. 1996. Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein. Cancer Res. 56:2299-2301.
46. Sonnenberg, E., D. Meyer, K. M. Weidner, and C. Birchmeier. 1993. Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development. J. Cell Biol. 123:223-235.
47. Steiner, M. S. 1995. Review of peptide growth factors in benign prostatic hyperplasia and urological malignancy. J. Urol. 153:1085-1096.
48. Stetler-Stevenson, W. G., L. A. Liotta, and D. E. J. Kleiner. 1993. Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J. 7:1434-1441.
49. Sugiura, Y., H. Shimada, R. C. Seeger, W. E. Laug, and Y. A. DeClerck. 1998. Matrix metalloproteinases-2 and -9 are expressed in human neuroblastoma: contribution of stromal cells to their production and correlation with metastasis. Cancer Res. 58:2209-2216.
50. Tashiro, K., M. Haglya, T. Nishizawa, T. Seki, M. Shimonishi, S. Shimizu, and T. Nakamura. 1990. Deduced primary structure of rat hepatocyte growth factor and expression of the mRNA in rat tissues. Proc. Natl. Acad. Sci. USA 87:3200-3204.
51. Thorgeirsson, U. P., L. A. Liotta, T. Kalebic, I. M. Margulies, K. Thomas, M. Rios-Candelore, and R. G. Russo. 1982. Effect of natural protease inhibitors and a chemoattractant on tumor cell invasion in vitro. J. Natl. Cancer Inst. 69:1049-1054.
52. Tsao, M. S., H. Zhu, A. Giaid, J. Viallet, T. Nakamura, and M. Park. 1993. Hepatocyte growth factor/scatter factor is an autocrine factor for human normal bronchial epithelial and lung carcinoma cells. Cell Growth Differ. 4:571-579.
53. Tsarfaty, I., J. H. Resau, S. Rulong, I. Keydar, D. L. Faletto, and G. F. Vande Woude. 1992. The met proto-oncogene receptor and lumen formation. Science 257:1258-1261.
54. Tsarfaty, I., S. Rong, J. H. Resau, S. Rulong, P. Pinto da Silva, and G. F. Vande Woude. 1994. Met mediated signaling in mesenchymal to epithelial cell conversion. Science 263:98-101.
55. Tso, J. Y., X. H. Sun, T.-H. Kao, K. S. Reece, and R. Wu. 1985. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acids Res. 13:2485-2502.
56. Walther, M. M., D. E. Kleiner, I. A. Lubensky, R. Pozzatti, T. Nyguen, J. R. Gnarra, K. Hurley, D. Venzon, W. M. Linehan, and W. G. Stetler-Stevenson. 1997. Progelatinase A mRNA expression in cell lines derived from tumors in patients with metastatic renal cell carcinoma correlates inversely with survival. Urology 50:295-301.
57. Woessner, J. F., Jr. 1991. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5:2145-2154.
58. Woolf, A. S., M. Kolatsi-Joannou, P. Haidman, E. Andermarcher, C. Moorby, L. G. Fine, P. S. Jat, M. D. Noble, and E. Gherardi. 1995. Roles of hepatocyte growth factor/scatter factor and the met receptor in the early development of the metanephros. J. Cell Biol. 128:171-184.
59. Zarnegar, R., and M. C. DeFrances. 1993. Expression of HGF-SF in normal and malignant human tissues. EXS 65:181-199.